Cargando…

Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism

BACKGROUND: An absent dorsolateral nigral hyperintensity (DNH) is a common finding in patients with neurodegenerative parkinsonism at high or ultra‐high field susceptibility‐weighted magnetic resonance imaging (SWI). OBJECTIVE: Despite increasing use of high field magnetic resonance imaging (MRI) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossauer, Anna, Müller, Christoph, Hussl, Anna, Krismer, Florian, Schocke, Michael, Gizewski, Elke, Mahlknecht, Philipp, Scherfler, Christoph, Wenning, Gregor K., Poewe, Werner, Seppi, Klaus, Heim, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272900/
https://www.ncbi.nlm.nih.gov/pubmed/37332641
http://dx.doi.org/10.1002/mdc3.13736
_version_ 1785059601017733120
author Grossauer, Anna
Müller, Christoph
Hussl, Anna
Krismer, Florian
Schocke, Michael
Gizewski, Elke
Mahlknecht, Philipp
Scherfler, Christoph
Wenning, Gregor K.
Poewe, Werner
Seppi, Klaus
Heim, Beatrice
author_facet Grossauer, Anna
Müller, Christoph
Hussl, Anna
Krismer, Florian
Schocke, Michael
Gizewski, Elke
Mahlknecht, Philipp
Scherfler, Christoph
Wenning, Gregor K.
Poewe, Werner
Seppi, Klaus
Heim, Beatrice
author_sort Grossauer, Anna
collection PubMed
description BACKGROUND: An absent dorsolateral nigral hyperintensity (DNH) is a common finding in patients with neurodegenerative parkinsonism at high or ultra‐high field susceptibility‐weighted magnetic resonance imaging (SWI). OBJECTIVE: Despite increasing use of high field magnetic resonance imaging (MRI) in specialized centers, these scanners are still frequently unavailable in primary care or outpatient facilities and underdeveloped or emerging countries. Therefore, the aim of the present study was to evaluate the diagnostic utility of DNH assessment at 1.5 versus 3 T MRI to distinguish patients with neurodegenerative parkinsonism, including Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), from healthy controls (HC). METHODS: Absence of DNH was assessed on visual inspection of anonymized 1.5 T and 3.0 T SWI scans in a case–control study including 86 patients with neurodegenerative parkinsonism and 33 healthy controls (HC). All study participants were consecutively recruited to undergo 1.5 and 3 T MRI. RESULTS: Overall correct classification was 81.7% (95% CI, 72.6–88.4%) for 1.5 T and 95.7% (95% CI, 89.1–98.7%) for 3 T MRI in discriminating neurodegenerative parkinsonism from controls. However, while DNH was bilaterally present in all but one of the HC at 3 T MRI, it was rated as abnormal (at least unilateral absence) in 15 of 22 HC at 1.5 T MRI, resulting in a specificity of 31.8%. CONCLUSIONS: The results of the present study demonstrate an insufficient specificity of visual assessment of DNH at 1.5 T MRI for the diagnosis of neurodegenerative parkinsonism.
format Online
Article
Text
id pubmed-10272900
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-102729002023-06-17 Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism Grossauer, Anna Müller, Christoph Hussl, Anna Krismer, Florian Schocke, Michael Gizewski, Elke Mahlknecht, Philipp Scherfler, Christoph Wenning, Gregor K. Poewe, Werner Seppi, Klaus Heim, Beatrice Mov Disord Clin Pract Research Articles BACKGROUND: An absent dorsolateral nigral hyperintensity (DNH) is a common finding in patients with neurodegenerative parkinsonism at high or ultra‐high field susceptibility‐weighted magnetic resonance imaging (SWI). OBJECTIVE: Despite increasing use of high field magnetic resonance imaging (MRI) in specialized centers, these scanners are still frequently unavailable in primary care or outpatient facilities and underdeveloped or emerging countries. Therefore, the aim of the present study was to evaluate the diagnostic utility of DNH assessment at 1.5 versus 3 T MRI to distinguish patients with neurodegenerative parkinsonism, including Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), from healthy controls (HC). METHODS: Absence of DNH was assessed on visual inspection of anonymized 1.5 T and 3.0 T SWI scans in a case–control study including 86 patients with neurodegenerative parkinsonism and 33 healthy controls (HC). All study participants were consecutively recruited to undergo 1.5 and 3 T MRI. RESULTS: Overall correct classification was 81.7% (95% CI, 72.6–88.4%) for 1.5 T and 95.7% (95% CI, 89.1–98.7%) for 3 T MRI in discriminating neurodegenerative parkinsonism from controls. However, while DNH was bilaterally present in all but one of the HC at 3 T MRI, it was rated as abnormal (at least unilateral absence) in 15 of 22 HC at 1.5 T MRI, resulting in a specificity of 31.8%. CONCLUSIONS: The results of the present study demonstrate an insufficient specificity of visual assessment of DNH at 1.5 T MRI for the diagnosis of neurodegenerative parkinsonism. John Wiley & Sons, Inc. 2023-04-14 /pmc/articles/PMC10272900/ /pubmed/37332641 http://dx.doi.org/10.1002/mdc3.13736 Text en © 2023 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Grossauer, Anna
Müller, Christoph
Hussl, Anna
Krismer, Florian
Schocke, Michael
Gizewski, Elke
Mahlknecht, Philipp
Scherfler, Christoph
Wenning, Gregor K.
Poewe, Werner
Seppi, Klaus
Heim, Beatrice
Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
title Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
title_full Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
title_fullStr Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
title_full_unstemmed Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
title_short Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
title_sort dorsolateral nigral hyperintensity on 1.5 t versus 3 t susceptibility‐weighted magnetic resonance imaging in neurodegenerative parkinsonism
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272900/
https://www.ncbi.nlm.nih.gov/pubmed/37332641
http://dx.doi.org/10.1002/mdc3.13736
work_keys_str_mv AT grossaueranna dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT mullerchristoph dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT husslanna dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT krismerflorian dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT schockemichael dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT gizewskielke dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT mahlknechtphilipp dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT scherflerchristoph dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT wenninggregork dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT poewewerner dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT seppiklaus dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism
AT heimbeatrice dorsolateralnigralhyperintensityon15tversus3tsusceptibilityweightedmagneticresonanceimaginginneurodegenerativeparkinsonism